E
Manhattan Scientifics, Inc.
MHTX
$0.0001
$0.000.00%
E
Sell
3/7/2025Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to E+ from E on 3/7/2025 due to an increase in the volatility index and total return index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to E+ from E on 3/7/2025 due to an increase in the volatility index and total return index.
E
Sell
2/20/2025Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to E from E+ on 2/20/2025 due to a decline in the volatility index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to E from E+ on 2/20/2025 due to a decline in the volatility index.
E
Sell
1/23/2025Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to E+ from E on 1/23/2025 due to an increase in the volatility index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to E+ from E on 1/23/2025 due to an increase in the volatility index.
E
Sell
1/8/2025Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to E from E+ on 1/8/2025 due to a decline in the volatility index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to E from E+ on 1/8/2025 due to a decline in the volatility index.
E
Sell
10/23/2024Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to E+ from E on 10/23/2024 due to an increase in the total return index and volatility index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to E+ from E on 10/23/2024 due to an increase in the total return index and volatility index.
E
Sell
10/8/2024Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to E from E+ on 10/8/2024 due to a significant decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.02 to 0.02.
Manhattan Scientifics, Inc. (MHTX) was downgraded to E from E+ on 10/8/2024 due to a significant decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.02 to 0.02.
E
Sell
7/26/2023Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D- on 7/26/2023 due to a decline in the volatility index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D- on 7/26/2023 due to a decline in the volatility index.
D
Sell
7/11/2023Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D- from E+ on 7/11/2023 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 13.79% from -$87 to -$75.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D- from E+ on 7/11/2023 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 13.79% from -$87 to -$75.
E
Sell
5/5/2023Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D- on 5/5/2023 due to a noticeable decline in the volatility index, solvency index and valuation index. Debt to equity increased from -0.11 to -0.06, and the quick ratio declined from 0.18 to 0.1.
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D- on 5/5/2023 due to a noticeable decline in the volatility index, solvency index and valuation index. Debt to equity increased from -0.11 to -0.06, and the quick ratio declined from 0.18 to 0.1.
D
Sell
3/14/2023Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 03/14/2023.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 03/14/2023.
D
Sell
2/23/2023Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from D- on 02/23/2023.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index.
D
Sell
11/22/2022Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from D- on 11/22/2022 due to a noticeable increase in the volatility index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from D- on 11/22/2022 due to a noticeable increase in the volatility index.
D
Sell
10/19/2022Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D- from E+ on 10/19/2022 due to an increase in the volatility index and total return index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D- from E+ on 10/19/2022 due to an increase in the volatility index and total return index.
E
Sell
10/4/2022Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D- on 10/4/2022 due to a decline in the volatility index, total return index and efficiency index. Net income declined 149.77% from -$647 to -$1.62M, and total capital declined 101.71% from $1.58M to -$27.
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D- on 10/4/2022 due to a decline in the volatility index, total return index and efficiency index. Net income declined 149.77% from -$647 to -$1.62M, and total capital declined 101.71% from $1.58M to -$27.
D
Sell
5/18/2022Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 5/18/2022 due to a noticeable decline in the solvency index, volatility index and valuation index. Debt to equity increased from 0.13 to 0.35, and the quick ratio declined from 0.39 to 0.29.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 5/18/2022 due to a noticeable decline in the solvency index, volatility index and valuation index. Debt to equity increased from 0.13 to 0.35, and the quick ratio declined from 0.39 to 0.29.
D
Sell
5/16/2022Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
D
Sell
4/21/2022Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
E
Sell
4/20/2022Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index, solvency index and volatility index. The quick ratio declined from 0.54 to 0.39, and debt to equity increased from 0.12 to 0.13.
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index, solvency index and volatility index. The quick ratio declined from 0.54 to 0.39, and debt to equity increased from 0.12 to 0.13.
D
Sell
11/17/2021Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D from D+ on 11/17/2021 due to a significant decline in the valuation index, efficiency index and volatility index. Total capital declined 33.79% from $3.4M to $2.25M.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D from D+ on 11/17/2021 due to a significant decline in the valuation index, efficiency index and volatility index. Total capital declined 33.79% from $3.4M to $2.25M.
D
Sell
11/4/2021Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D+ from D on 11/4/2021 due to a noticeable increase in the volatility index and valuation index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D+ from D on 11/4/2021 due to a noticeable increase in the volatility index and valuation index.
D
Sell
10/6/2021Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D from C- on 10/6/2021 due to a significant decline in the total return index and volatility index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D from C- on 10/6/2021 due to a significant decline in the total return index and volatility index.
C
Hold
10/5/2021Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to C- from D on 10/5/2021 due to a significant increase in the total return index and volatility index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to C- from D on 10/5/2021 due to a significant increase in the total return index and volatility index.
D
Sell
10/4/2021Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D from C- on 10/4/2021 due to a significant decline in the total return index and volatility index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D from C- on 10/4/2021 due to a significant decline in the total return index and volatility index.
C
Hold
10/1/2021Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to C- from D on 10/1/2021 due to a significant increase in the total return index and volatility index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to C- from D on 10/1/2021 due to a significant increase in the total return index and volatility index.
D
Sell
9/14/2021Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D from D+ on 9/14/2021 due to a large decline in the growth index, volatility index and valuation index. Earnings per share declined from $0.0002 to -$0.0046, and operating cash flow declined 6.25% from -$96 to -$102.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D from D+ on 9/14/2021 due to a large decline in the growth index, volatility index and valuation index. Earnings per share declined from $0.0002 to -$0.0046, and operating cash flow declined 6.25% from -$96 to -$102.
D
Sell
8/23/2021Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D+ from C on 8/23/2021 due to a significant decline in the total return index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D+ from C on 8/23/2021 due to a significant decline in the total return index.
C
Hold
8/17/2021Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to C from D+ on 8/17/2021 due to a substantial increase in the total return index and volatility index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to C from D+ on 8/17/2021 due to a substantial increase in the total return index and volatility index.
D
Sell
5/18/2021Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D+ from C on 5/18/2021 due to a significant decline in the total return index, efficiency index and growth index. Earnings per share declined from $0.0055 to $0.0002, net income declined 95.14% from $2.76M to $134, and EBIT declined 4.55% from -$176 to -$184.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D+ from C on 5/18/2021 due to a significant decline in the total return index, efficiency index and growth index. Earnings per share declined from $0.0055 to $0.0002, net income declined 95.14% from $2.76M to $134, and EBIT declined 4.55% from -$176 to -$184.
C
Hold
1/4/2021Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to C from C- on 1/4/2021 due to a significant increase in the total return index and volatility index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to C from C- on 1/4/2021 due to a significant increase in the total return index and volatility index.
C
Hold
12/16/2020Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to C- from C on 12/16/2020 due to a major decline in the valuation index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to C- from C on 12/16/2020 due to a major decline in the valuation index.
C
Hold
11/20/2020Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to C from D on 11/20/2020 due to a significant increase in the efficiency index, valuation index and total return index. Total capital increased 2,985% from -$60 to $1.73M, and net income increased 233.52% from $528 to $1.76M.
Manhattan Scientifics, Inc. (MHTX) was upgraded to C from D on 11/20/2020 due to a significant increase in the efficiency index, valuation index and total return index. Total capital increased 2,985% from -$60 to $1.73M, and net income increased 233.52% from $528 to $1.76M.
D
Sell
12/27/2019Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from D- on 12/27/2019 due to an increase in the total return index and volatility index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from D- on 12/27/2019 due to an increase in the total return index and volatility index.
D
Sell
12/5/2019Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 12/5/2019 due to a decline in the volatility index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 12/5/2019 due to a decline in the volatility index.
D
Sell
11/20/2019Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from D- on 11/20/2019 due to a noticeable increase in the growth index, efficiency index and total return index. Total capital increased 1,781.16% from -$69 to $1.16M, net income increased 235.35% from -$908 to $1.23M, and earnings per share increased from -$0.0017 to $0.0021.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from D- on 11/20/2019 due to a noticeable increase in the growth index, efficiency index and total return index. Total capital increased 1,781.16% from -$69 to $1.16M, net income increased 235.35% from -$908 to $1.23M, and earnings per share increased from -$0.0017 to $0.0021.
D
Sell
7/18/2019Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D- from E+ on 7/18/2019 due to an increase in the volatility index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D- from E+ on 7/18/2019 due to an increase in the volatility index.
E
Sell
12/19/2018Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D- on 12/19/2018 due to a decline in the growth index and volatility index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D- on 12/19/2018 due to a decline in the growth index and volatility index.
D
Sell
11/27/2018Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D- from E+ on 11/27/2018 due to an increase in the valuation index, solvency index and volatility index. The quick ratio increased from 0.07 to 0.14.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D- from E+ on 11/27/2018 due to an increase in the valuation index, solvency index and volatility index. The quick ratio increased from 0.07 to 0.14.
E
Sell
10/29/2018Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D- on 10/29/2018 due to a decline in the volatility index, solvency index and valuation index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D- on 10/29/2018 due to a decline in the volatility index, solvency index and valuation index.
D
Sell
8/21/2018Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 8/21/2018 due to a significant decline in the valuation index, efficiency index and solvency index. Total capital declined 21.45% from $6.39M to $5.02M.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 8/21/2018 due to a significant decline in the valuation index, efficiency index and solvency index. Total capital declined 21.45% from $6.39M to $5.02M.
D
Sell
4/18/2018Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from D- on 4/18/2018 due to a significant increase in the valuation index, efficiency index and growth index. Earnings per share increased from -$0.0011 to $0.0032, net income increased 377.54% from -$610 to $1.69M, and operating cash flow increased 97.77% from -$8.22M to -$183.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from D- on 4/18/2018 due to a significant increase in the valuation index, efficiency index and growth index. Earnings per share increased from -$0.0011 to $0.0032, net income increased 377.54% from -$610 to $1.69M, and operating cash flow increased 97.77% from -$8.22M to -$183.
D
Sell
11/14/2017Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 11/14/2017 due to a major decline in the growth index, solvency index and valuation index. Operating cash flow declined 193.96% from $8.75M to -$8.22M, EBIT declined 174.4% from $332 to -$247, and earnings per share declined from $0.004 to -$0.0011.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 11/14/2017 due to a major decline in the growth index, solvency index and valuation index. Operating cash flow declined 193.96% from $8.75M to -$8.22M, EBIT declined 174.4% from $332 to -$247, and earnings per share declined from $0.004 to -$0.0011.
D
Sell
8/18/2017Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from D- on 8/18/2017 due to a major increase in the growth index, efficiency index and total return index. Operating cash flow increased 869.83% from -$1.14M to $8.75M, earnings per share increased from -$0.0022 to $0.004, and net income increased 279.1% from -$1.18M to $2.12M.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D from D- on 8/18/2017 due to a major increase in the growth index, efficiency index and total return index. Operating cash flow increased 869.83% from -$1.14M to $8.75M, earnings per share increased from -$0.0022 to $0.004, and net income increased 279.1% from -$1.18M to $2.12M.
D
Sell
5/17/2017Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to D- from E+ on 5/17/2017 due to an increase in the valuation index, solvency index and growth index. The quick ratio increased from 0.65 to 1.37, and debt to equity declined from 0.89 to 0.06.
Manhattan Scientifics, Inc. (MHTX) was upgraded to D- from E+ on 5/17/2017 due to an increase in the valuation index, solvency index and growth index. The quick ratio increased from 0.65 to 1.37, and debt to equity declined from 0.89 to 0.06.
E
Sell
4/18/2017Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D- on 4/18/2017 due to a large decline in the total return index, solvency index and volatility index. The quick ratio declined from 0.92 to 0.65, and debt to equity increased from 0.72 to 0.89.
Manhattan Scientifics, Inc. (MHTX) was downgraded to E+ from D- on 4/18/2017 due to a large decline in the total return index, solvency index and volatility index. The quick ratio declined from 0.92 to 0.65, and debt to equity increased from 0.72 to 0.89.
D
Sell
5/19/2016Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 5/19/2016 due to a significant decline in the valuation index, efficiency index and growth index. EBIT declined 37.28% from -$1.29M to -$1.78M, net income declined 33.99% from -$1.42M to -$1.9M, and operating cash flow declined 30.11% from -$1.11M to -$1.44M.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D- from D on 5/19/2016 due to a significant decline in the valuation index, efficiency index and growth index. EBIT declined 37.28% from -$1.29M to -$1.78M, net income declined 33.99% from -$1.42M to -$1.9M, and operating cash flow declined 30.11% from -$1.11M to -$1.44M.
D
Sell
3/11/2016Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to D from C- on 3/11/2016 due to a major decline in the volatility index and total return index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to D from C- on 3/11/2016 due to a major decline in the volatility index and total return index.
C
Hold
2/10/2016Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to C- from C on 2/10/2016 due to a large decline in the volatility index and total return index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to C- from C on 2/10/2016 due to a large decline in the volatility index and total return index.
C
Hold
2/4/2016Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to C from C+ on 2/4/2016 due to a noticeable decline in the volatility index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to C from C+ on 2/4/2016 due to a noticeable decline in the volatility index.
C
Hold
1/21/2016Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to C+ from B- on 1/21/2016 due to a decline in the volatility index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to C+ from B- on 1/21/2016 due to a decline in the volatility index.
B
Buy
1/12/2016Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to B- from B on 1/12/2016 due to a large decline in the volatility index and total return index.
Manhattan Scientifics, Inc. (MHTX) was downgraded to B- from B on 1/12/2016 due to a large decline in the volatility index and total return index.
B
Buy
12/28/2015Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to B from B- on 12/28/2015 due to a noticeable increase in the growth index, total return index and valuation index. Operating cash flow increased 19.35% from -$1.18M to -$1.41M, and earnings per share increased from -$0.0039 to -$0.004.
Manhattan Scientifics, Inc. (MHTX) was upgraded to B from B- on 12/28/2015 due to a noticeable increase in the growth index, total return index and valuation index. Operating cash flow increased 19.35% from -$1.18M to -$1.41M, and earnings per share increased from -$0.0039 to -$0.004.
B
Buy
10/28/2015Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to B- from C+ on 10/28/2015 due to a major increase in the volatility index and total return index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to B- from C+ on 10/28/2015 due to a major increase in the volatility index and total return index.
C
Hold
8/27/2015Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to C+ from C- on 8/27/2015 due to a substantial increase in the volatility index.
Manhattan Scientifics, Inc. (MHTX) was upgraded to C+ from C- on 8/27/2015 due to a substantial increase in the volatility index.
C
Hold
8/14/2015Downgrade
Manhattan Scientifics, Inc. (MHTX) was downgraded to C- from C on 8/14/2015 due to a large decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.02 to -$0.0039, operating cash flow declined 116.58% from $7.11M to -$1.18M, and net income declined 114.86% from $13.52M to -$2.01M.
Manhattan Scientifics, Inc. (MHTX) was downgraded to C- from C on 8/14/2015 due to a large decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.02 to -$0.0039, operating cash flow declined 116.58% from $7.11M to -$1.18M, and net income declined 114.86% from $13.52M to -$2.01M.
C
Hold
5/20/2015Upgraded
Manhattan Scientifics, Inc. (MHTX) was upgraded to C from D on 5/20/2015 due to a significant increase in the valuation index, efficiency index and solvency index. Total capital increased 438.02% from $3.19M to $17.15M, the quick ratio increased from 1.41 to 5.27, and debt to equity declined from -3.56 to 0.23.
Manhattan Scientifics, Inc. (MHTX) was upgraded to C from D on 5/20/2015 due to a significant increase in the valuation index, efficiency index and solvency index. Total capital increased 438.02% from $3.19M to $17.15M, the quick ratio increased from 1.41 to 5.27, and debt to equity declined from -3.56 to 0.23.
OTC PK
03/06/2025 11:05AM Eastern
Quotes delayed
